US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Articles published by Rafael Holdings, Inc.

News headline image
Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers CYTH RFL
News headline image
Rafael Holdings Announces up to $5 Million Share Repurchase Program
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL
News headline image
Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities
From Rafael Holdings, Inc.
Via GlobeNewswire
Tickers RFL